Intellectual Property India Publishes Patent Application for 'Epidermal Growth Factor Receptor Variant III Antibodies' Filed by Ibio Inc.

MUMBAI, India, May 30 -- Intellectual Property India has published a patent application (202517044907 A) filed by Ibio Inc., San Diego, on May 9, for 'epidermal growth factor receptor variant iii antibodies.'

Inventor(s) include Phan Dillon; Hsu Tom Sih Yuan; Greving Matthew P; Brenner Martin; Phuong Tam Thi Thanh; Taguchi Alexander Tomoaki; Schwartz Cory; Liu Gao; and Chen Jiang.

The application for the patent was published on May 30, under issue no. 22/2025.

According to the abstract released by the Intellectual Property India: "Provided herein are anti EGFRvIII antibodies and binding fragments thereof. The anti EGFRvIII antibodies of the disclosure are useful for the treatment of cancers through e.g. antibody dependent cell cytotoxici...